Round­ing up the Honey Bees (2)

This is the 2nd part of a lon­gread, 1,550 words – 9 min read­ing – still "left over" af­ter the first part went on­line last week. I bor­rowed the ti­tle from TWiM episode #178 for the ir­re­sistible pun, just adding a drop of ho­ney.

by Christoph

From mi­cro­biota to species, to strains, to genes

Glyphosate is a com­pet­i­tive in­hibitor of the shiki­mate path­way that mi­crobes and plants use for the syn­the­sis of three aro­matic amino acids (Trp,Phe,Tyr) and their de­riv­a­tives. In E. coli, for­ma­tion of 5‑enolpyru­vyl­shiki­mate-3-phos­phate (EPSP) from shiki­mate-3-phos­phate (S3P) and phos­pho­­en­ol-pyru­vate (PEP) is cat­alyzed by the AroA en­zyme (EPSPS = EPSP syn­thase). Glyphosate com­petes with PEP for bind­ing to EPSP syn­thase in a con­cen­tra­tion-de­pen­dent man­ner, that is, it does not ir­reversibly in­ac­ti­vate the en­zyme but cre­ates a road­block in the syn­the­sis of an es­sen­tial meta­bolic in­ter­me­di­ate. This, then, leads to starv­ing of the cells, re­tar­da­tion of their growth, and their even­tu­al demise. Con­se­quently, E. coli can be res­cued from the growth-in­hibitory ac­tion of glyphosate by in­creas­ing the aroA gene copy num­ber via a mul­ti­copy plas­mid. EPSP syn­thases from plants and most bac­te­ria are sen­si­tive to glyphosate (class I EPSPS) but glyphosate-tol­er­ant vari­ants (class II EPSPS) have also been iden­ti­fied, se­lected for in the lab, or iso­lated "in the wild" from va­ri­ous bac­teria. A pro­to­type of the lat­ter is a class II EPSPS from Agrobac­terium tume­fa­ciens strain CP4, which sur­vived in a glyphosate man­u­fac­tur­ing waste stream, and which was – just for the re­cord – in­stru­mental in de­vel­op­ing glyphosate-tol­er­ant crop, "gene maize" for ex­am­ple.

Fig­ure 1. Bees dosed with the her­bi­cide glypho­sate to see how it af­fected mi­crobes in their di­gestive sys­tems, us­ing paint mark­ings to track which bees got the chem­i­cal. Cour­tesy of Vi­vian Abagiu, The Uni­ver­sity of Texas, Austin TX

The "core species" of the honey bee mi­cro­biota are cul­ti­vable, which al­lowed Motta et al. to as­say their suscep­ti­bi­li­ty to glyphosate in­di­vid­u­ally. The growth of var­i­ous Lac­to­bacil­lus Firm‑4 and Bar­tonella apis strains iso­lated from bees was not af­fected by 10 mM glyphosate (Lacto­ba­cillus Firm‑5 were ex­cluded from these as­says as they lack EPSP syn­thetase), while growth of Bi­fi­dobac­terium, Gil­amella api­cola, and Snod­gras­sella alvi strains was de­layed or fully in­hib­ited at this con­cen­tra­tion. How­ever, the growth of three iso­lates, G. api­cola App4-10, S. alvi strains wkB2 and wkB298, was only re­duced by 10 – 30% by glyphosate. DNA se­quenc­ing of the aroA genes of these iso­lates re­vealed that Lac­to­bacil­lus Firm‑4 and B. apis strains had glyphosate-tol­er­ant class II EPSP syn­the­tases, while Bi­fi­dobac­terium, G. api­cola, and S. alvi strains had glyphosate-sen­si­tive class I EPSP syn­thetases (also S. alvi strains wkB2 and wkB298, but see be­low).

These re­sults con­firmed that not the bees but their mi­cro­biota are (aha!) the pri­mary tar­get of gly­phosate. Also, the re­sults could ex­plain, at least in part, the ob­served changes in the pro­por­tional species com­po­si­tion of the bee mi­cro­biota in the hive ex­per­i­ments (Fig­ure 1). S. alvi de­pends on the shiki­mate path­way to suc­cess­fully col­o­nize and thrive in the bee hindgut where the concentra­tions of aro­matic amino acids are low. Im­ped­ing this path­way by glyphosate would re­sult in a drop of S. alvi and, for the same rea­son, of Bi­fi­dobac­terium abun­dance, as was ob­served. The au­thors have no rea­son­able ex­pla­na­tion for the ob­served in­crease in abun­dance in the hive ex­per­i­ment of G. api­cola, which has a glyphosate-sen­si­tive class I EPSPS. The abun­dances of Lac­to­bacil­lus Firm‑4 (class II EPSPS), and Firm‑5 (no EPSPS) were re­duced in the hive ex­per­i­ment. But this was prob­a­bly not a di­rect ef­fect of glyphosate be­cause these species are de­fi­cient in later steps of aro­matic ami­no acid biosyn­the­sis and de­pend, there­fore, on cross-feed­ing by other mem­bers of the gut micro­biota such as S. alvi that re­lease aro­matic amino acids.

Fig­ure 2. Growth curves of E. coli ΔaroA BW25­113 ex­press­ing the aroA gene from dif­fer­ent bee-as­so­ci­ated bac­te­r­ial strains (B. apis in red, E. coli in black, G. api­cola in blue, and S. alvi in green) cul­tured in min­i­mal me­dia in the pre­sence or ab­sence of 10 mM glyphosate. Source

The de­tec­tive work of Motta et al. didn't stop here. In a clas­si­cal com­ple­men­ta­tion as­say, they found that an E. coli ΔaroA mu­tant fails to grow on min­i­mal me­dia but grows nor­mally when trans­formed with an ara­bi­nose-in­ducible plas­mid car­ry­ing the E. coli ΔaroA gene in the pres­ence of ara­bi­nose (Fig­ure 4, left panel). Since the E. coli AroA en­zyme is a class I EPSPS, growth of such in­du­ced trans­for­mants was strongly de­layed, as ex­pected, in the pres­ence of 10 mM glyphosate (Fig­ure 4, right panel). Tested in the same man­ner, the aroA genes of four S. al­vi strains, one B. apis, and one G. api­cola strain, fully com­ple­mented the E. coli ΔaroA host in the ab­sence of glyphosate, with vir­tu­ally no de­lay in growth re­sponse to 10 mM glyphosate for B. apis wkB233A AroA, a class II EPSPS. AroA en­zymes of G. api­cola and the four S. alvi strains, all class I EP­SPSs, were sen­si­tive to glyphosate like E. coli AroA (Fig­ure 4). Motta et al. could "speed up" the growth of all trans­for­mant strains by ei­ther low­er­ing the glyphosate con­cen­tra­tion or in­creas­ing the in­ducer con­cen­tra­tion, re­sults which cor­rob­o­rate the re­versible mech­a­nism of EPSPS in­hi­bi­tion by glypho­sate.

The com­ple­men­ta­tion as­says for the S. alvi AroA en­zymes re­vealed some­thing in­trigu­ing yet also rather trou­bling: they var­ied con­sid­er­ably in their re­sponse to glyphosate (Fig­ure 4, right panel). S. alvi strains wkB2 and wkB298, which both achieved bet­ter growth than ten other iso­lates in 10 mM glyphosate-con­tain­ing medium (see above), have par­tic­u­larly sen­si­tive AroA en­zymes. This was un­expected but mi­cro­bi­ol­o­gists are used to such "sur­prises": these two strains had appa­rent­ly acqui­red a par­tial glyphosate re­sis­tance with a so far un­known mech­a­nism. Note that it's vir­tu­ally im­pos­­sible to trace this bee line in or­der to de­tect an instance(s) where it was un­in­ten­tion­ally ex­posed to glyphosate, se­lect­ing for glyphosate-tol­er­ant S. alvi strains (glyphosate be­ing used as her­bi­cide in large amounts in agri­cul­ture for >40 years). More trou­bling, though, is the fol­low­ing con­se­quence of their find­ing: if an ef­fec­tive sub­stance elic­its dif­fer­ent re­sponses of the cel­lu­lar tar­get in an al­lele-de­pen­dent man­ner, then changes in cell num­bers of one species in a micro­bio­ta be­com­es no more than an "ini­tial sus­pi­cion", that is, of lim­ited sig­nif­i­cance with­out care­fully dis­sect­ing the proportio­nal strain com­po­si­tion of this species and the strains' in­di­vid­ual respon­ses to the sub­stance. This means, to put it bluntly, "farewell" to es­tab­lished phar­ma­ceu­ti­cal do­se/response mea­sure­ments, and "wel­come" to mul­ti­vari­ate analy­ses. Motta et al. cau­tiously claim that "glyphosate per­turbs the gut mi­cro­biota of honey bees" in the ti­tle of their pa­per. They were thus cer­tainly aware that even their ex­ten­sive data set is in­suf­fi­cient to "go at full length" with a mul­ti­vari­ate analy­sis at this point. But the de­sign of their study is in line with such ef­forts that ra­pidly be­come stan­dard in microbio­me stud­ies. This was also no­ticed by Bayer AG since they im­me­diately is­sued a de­fen­sive state­ment (09/25) the day af­ter the Motta et al. pa­per was pub­lished (09/24), in which they sought to re­ject this study by claim­ing that "...reg­u­la­tory stud­ies on pesti­ci­des have to fol­low strict in­ter­na­tional guide­lines de­vel­oped by the Or­ga­ni­za­tion of Eco­nomic Co­operation and De­vel­op­ment (OECD) and other in­ter­na­tional or­ga­ni­za­tions, and in­clude end­points that are rel­e­vant to the pro­tec­tion of ho­ney bees." A more proac­tive de­fense could have in­cluded, in my per­sonal opin­ion, an of­fer to fund stud­ies for "...a re­al­is­tic as­sess­ment of the ex­tent to which the ob­served ef­fects might play a role in a real-life sce­nario by con­duct­ing stud­ies with en­tire bee colonies in the field" if they con­sider the "rel­a­tively small num­ber of in­di­vid­ual bees which were tested" in­suf­fi­cient. You may know that Bayer AG had ac­quired Mon­santo, for decades world lea­der in the pro­duc­tion of glypho­sa­te-con­tain­ing her­bi­cides, for a re­ported $66 bil­lion ear­lier this year.

An­i­mals lack the shiki­mate path­way and, there­fore, re­quire Trp and Phe as "es­sen­tial amino acids" for growth (Tyr can be de­rived from Phe) and for the syn­the­sis of fo­lates (vi­t­a­min B6), ubiquinones (coen­zyme Q10), and hor­mones, for ex­am­ple, sero­tonin, dopamine, and thy­rox­ine. Yet, lack­ing the shiki­mate path­way, an­i­mals were long thought to be largely in­sen­si­tive to glyphosate (the Accep­ta­b­le Daily In­take, ADI for hu­mans in the USA is 1.75 mg, in the EU 0.5 mg, per kilo­gram body weight per day), which was in­stru­men­tal in es­tab­lish­ing glyphosate as a "vir­tu­ally ideal her­bi­cide" un­likely to cause "col­lat­eral dam­age". It is known since the 1970s that glyphosate has an in­hibitory ef­fect on the growth of bac­te­ria, and thus it was no big sur­prise when a study found that it messes with the soil mi­cro­biota (here's an­other study). But an­i­mals are also likely to be af­fected by glyphosate via their gut mi­cro­biota. A re­cent study found that path­o­genic bac­te­ria in poul­try such as Salmo­nel­la en­ter­i­tidis, S. gal­li­narum, S. ty­phimurium, Clostrid­ium per­frin­gens and C. bot­u­linum were highly re­sis­tant to glyphosate, whereas ben­e­fi­cial bac­te­ria such as En­te­ro­coc­cus fae­calis, E. faeci­um, Bacil­lus ba­dius, Bi­fi­dobac­terium ado­les­cen­tis and Lac­to­bacil­lus sp. were mod­er­ately to highly suscept­ible. The au­thors of this study con­clude "a re­duc­tion of ben­e­fi­cial bac­te­ria in the gastroin­testinal tract mi­cro­biota by in­ges­tion of glyphosate could dis­turb the nor­mal gut bac­te­r­ial commu­nity." Claus et al. em­pha­size this point when they say: "If it were demon­strated that glyphosate in­duced sim­i­lar dys­bio­sis in mam­mals, then this would be of tox­i­co­log­i­cal rel­e­vance be­cause it would lead to a re­duc­tion of po­ten­tially ben­e­fi­cial bac­te­ria in the GI tract of the host." Motta et al. can show in their study that the gut mi­cro­biota of honey bees is per­turbed by glyphosate at "phy­sio­logical con­centrations" (as Michael Schmidt ten­ta­tively put in the TWiM #187 pod­cast, fully awa­re of this some­how lop­sided ex­pres­sion). They show, in ad­di­tion, that this "per­tur­ba­tion" causes an in­crease in sus­cep­ti­bil­ity of the bees to a known op­por­tunis­tic pathogen, Ser­ra­tia marcescens kz19. This is, to my knowl­edge, the first di­rect demon­stra­tion of fail­ure of an animal's im­mune sys­tem due to gly­phosate-in­duced al­ter­ation of its mi­cro­biota. No small feat, and worth the claim that this study "is cer­tain to make a con­tro­ver­sial her­bi­cide even more of a flash­point" (see in­tro to part 1).

The Motta et al. pa­per was also sub­ject in episode #187 of the pod­cast "This Week in Microbio­lo­gy" (TWiM), from minute 21:45 on.
 

Ref­er­ence

Motta EVS, Ray­mann K, Moran NA. (2018). Glyphosate per­turbs the gut mi­cro­biota of honey bees. Proc Natl Acad Sci U S A, 115 (41), 10305 – 10310, PMID 30249635 (Open Ac­cess PDF)

 

Other Posts